Quotient Limited Voluntarily Delisting Shares From Nasdaq, Laying off 100 Employees
The move would take company shares off the exchange by early January, ending efforts earlier this year to regain compliance with listing requirements.
Quotient Limited Completes 1-For-40 Reverse Stock Split
The split is intended to bring the company into compliance with the minimum bid price requirement for the Nasdaq Global Market.
Quotient Limited, Infynity Biomarkers Partner to Develop Infectious Disease Tests
The companies will work to expand Quotient's MosaiQ Serology Disease Screening menu and reduce the time and cost of assay development and commercialization.
Quotient Limited Fiscal Q4 Revenues Up 2 Percent
The firm had no revenues from its MosaiQ products, although it said that it has secured $1.4 million in orders for fiscal Q1 2023.
Quotient, Theradiag Announce Dx Partnership
Quotient said that it intends to develop a microarray-based test for connective tissue diseases with Theradiag.
Jul 9, 2021